Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Dec 08, 2022 8:55pm
125 Views
Post# 35160753

RE:RE:RE:RE:RE:RE:RE:RE:Pharmaceutical drug sales...

RE:RE:RE:RE:RE:RE:RE:RE:Pharmaceutical drug sales...subaru1, in a sense we are fortunate those at Labs recognized the need to change course as the regular mj companies are slowly fading away because there are so many retailers.  Every corner seems to have at least one and the market is saturated.  Look at the debt of some of these companies who were once mega giants in the sector.

Moving towards the pharma CBD space has been quite a journey for those of us holding through it, but I get the feeling that light at the end of the tunnel is no longer a locomotive, but actually day light on the other side.

Its been a tough couple years, but long term gain for short term pain is how I continue to look at it.................

I am amazed at how many unregulated outfits there are in Canada selling CBD products and if the government finally clamps down on them through regulatory requirements, that will bode well for Labs and once these big pharma announcements start happening, Medipharm will become relevant once again, but until that day the manipulators will continue to play with this one

Bring on a couple day halt for huge news, and watch the rats scurry for cover.............................
<< Previous
Bullboard Posts
Next >>